GATA1 mutational analysis in chronic myeloid leukaemia.

GATA1 mutational analysis in chronic myeloid leukaemia.

Opis bibliograficzny
Główni autorzy:	Halsey, C, Fisher, C, Strathdee, G, Gibson, B, Holyoake, T, Vyas, P, Graham, G
Format:	Journal article
Język:	English
Wydane:	2007

Podobne zapisy

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
od: Halsey, C, i wsp.
Wydane: (2006)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
od: Garnett, C, i wsp.
Wydane: (2019)

How do Gata1 and cohesin gene mutations contribute to the development of myeloid leukaemia?
od: Garnett, C
Wydane: (2020)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
od: Reinhardt, K, i wsp.
Wydane: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
od: Reinhardt, K, i wsp.
Wydane: (2010)

FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia
od: D Sorcini, i wsp.
Wydane: (2023-11-01)

Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia
od: Karamitros, D, i wsp.
Wydane: (2016)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
od: Alford, K, i wsp.
Wydane: (2011)

The Importance of Mutational Analysis in Chronic Myeloid Leukaemia for Treatment Choice
od: Hugues de Lavallade, i wsp.
Wydane: (2016-11-01)

Natural history of GATA-1 mutations in Down syndrome.
od: Ahmed, M, i wsp.
Wydane: (2003)

C/EBPalpha mutations in acute myeloid leukaemias.
od: Nerlov, C
Wydane: (2004)

Natural history of GATA1 mutations in Down syndrome.
od: Ahmed, M, i wsp.
Wydane: (2004)

Myelodysplastic syndrome due to somatic GATA1 mutation.
od: Freson, K, i wsp.
Wydane: (2004)

miR-1202 acts as anti-oncomiR in myeloid leukaemia by down-modulating GATA-1S expression
od: Raffaele Sessa, i wsp.
Wydane: (2024-02-01)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
od: Tunstall-Pedoe, O, i wsp.
Wydane: (2008)

Unprecedented behaviour of chronic myeloid leukaemia
od: Balambika RG, i wsp.
Wydane: (2016-07-01)

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.
od: Foroni, L, i wsp.
Wydane: (2011)

Chronic myeloid leukaemia with marked thrombocytosis
od: Jun Ooi, i wsp.
Wydane: (2021-02-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
od: R Edlin, i wsp.
Wydane: (2010-05-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
od: R Edlin, i wsp.
Wydane: (2010-05-01)

GATA2 mutations and overexpression in pediatric acute myeloid leukemia
od: Zhenzhen Yang, i wsp.
Wydane: (2019-08-01)

Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation
od: Robert R. West, i wsp.
Wydane: (2014-02-01)

A Myelodysplastic Syndrome Associated with a Clonal GATA1 Mutation.
od: Freson, K, i wsp.
Wydane: (2008)

Transcriptional regulation of GATA1
od: Drissen, R, i wsp.
Wydane: (2007)

Rapid parallel acquisition of somatic mutations after NPM1 in acute myeloid leukaemia evolution
od: Grove, C, i wsp.
Wydane: (2016)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
od: Boultwood, J, i wsp.
Wydane: (2004)

Slovenian recommendations for the management of chronic myeloid leukaemia
od: Irena Preložnik Zupan, i wsp.
Wydane: (2018-04-01)

Two ophthalmic presentations of chronic myeloid leukaemia
od: Miles Kiernan, i wsp.
Wydane: (2022-08-01)

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
od: Cross, N, i wsp.
Wydane: (2018)

EVI1 expression in acute myeloid leukaemia.
od: Langabeer, SE, i wsp.
Wydane: (2001)

Deletion of the major GATA1 enhancer HS 1 does not affect eosinophil GATA1 expression and eosinophil differentiation.
od: Guyot, B, i wsp.
Wydane: (2004)

PLATELET DYSFUNCTION AND MDS FEATURES DUE TO NOVEL SOMATIC GATA1 MUTATION
od: Freson, K, i wsp.
Wydane: (2010)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
od: Heald, B, i wsp.
Wydane: (2007)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
od: Sweeney, C
Wydane: (2021)

GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1.
od: Kuhl, C, i wsp.
Wydane: (2005)

Germline DNMT3A mutation in familial acute myeloid leukaemia
od: Courtney D. DiNardo, i wsp.
Wydane: (2021-05-01)

Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia
od: Christine S. Young, i wsp.
Wydane: (2015-06-01)

A rare case of an elderly male with progression to chronic myeloid leukaemia secondary to chronic lymphocytic leukaemia
od: Sakditad Saowapa, i wsp.
Wydane: (2024-03-01)

GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1
od: Kuhl, C, i wsp.
Wydane: (2005)

The genetics of chronic myeloid leukaemia and recent advancements in therapy
od: Alexander Wellington
Wydane: (2022-06-01)